Urodynamix and Pfizer Inc. Launch Promotional Program in Boston

Urodynamix Technologies Ltd. (TSX VENTURE:URO) and Pfizer Inc. today begin a
series of promotional programs to increase awareness of uroNIRS(TM) Bladder
Monitor technology among urologists, medical professionals, and key opinion
leaders. The first session in the series will be held in Boston, MA with
subsequent events scheduled to be held in New York, NY, Philadelphia, PA, and
Washington, DC in December 2008. Urodynamix and Pfizer Inc. plan further
sessions across the US beginning in January 2009. 


These programs will be coordinated by Pfizer's Urology division and will feature
various keynote speakers. In Boston, Dr. Alexis Te, MD, Associate Professor of
Urology at Cornell University will introduce Urodynamix's uroNIRS(TM)
technology, a non-invasive medical device that uses near infrared spectroscopy
(NIRS) for the functional evaluation of the bladder to aid in the diagnosis and
treatment of lower urinary tract symptoms (LUTS). Dr. Te will discuss the
results of his work using NIRS over the past six months in addition to previous
published research.


"We are very excited about the opportunity to collaborate with Pfizer and our
leading distribution partners to deliver the message about UroNIRS(TM)
products," said Barry Allen, President and CEO of Urodynamix.


About Urodynamix Technologies Ltd.

Urodynamix Technologies is a Canadian medical device company developing and
commercializing non-invasive medical technology based on proprietary
applications of near-infrared spectroscopy (NIRS). The Company is currently
focused on products that aid in the diagnosis and treatment of urinary
incontinence, lower urinary tract symptoms, erectile dysfunction, prostate
cancer, benign prostatic hyperplasia, and traumatic increases in intra-abdominal
pressure that cause abdominal compartment syndrome. Urodynamix's breakthrough
medical technology has the potential to beneficially affect more than 200
million people worldwide.


About Pfizer Inc.

Founded in 1849, Pfizer is the world's largest research-based pharmaceutical
company. Pfizer is taking new approaches to advancing better health as it
discovers, develops, manufactures and delivers quality, safe and effective
prescription medicines to treat and help prevent disease for both people and
animals. For more information visit www.pfizer.com.


Certain information contained in this press release may be forward-looking and
is subject to unknown risks, which could cause actual results to differ
materially from those set forth or implied herein. Although the Company believes
that the expectations reflected in such forward-looking statements are
reasonable, it can give no assurance that such expectations will prove correct.

Urodynamix Technologies Ltd. (TSXV:URO)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024